Mirae Asset Global Investments Co., Ltd. Precision Biosciences Inc Transaction History

Mirae Asset Global Investments Co., Ltd.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 26, 2022	SELL	$1.15 - $3.34 $178,972 - $519,797	-155,628 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$2.96 - $7.76 $85,088 - $223,068	-28,746 Reduced 15.59%	155,628 $480,000
Q4 2021 Feb 08, 2022	BUY	$7.4 - $11.66 $354,608 - $558,747	47,920 Added 35.12%	184,374 $1.36 Million
Q3 2021 Nov 15, 2021	BUY	$9.18 - $14.15 $235,200 - $362,537	25,621 Added 23.12%	136,454 $1.58 Million
Q2 2021 Aug 11, 2021	BUY	$8.07 - $12.52 $127,804 - $198,279	15,837 Added 16.67%	110,833 $1.39 Million
Q1 2021 May 13, 2021	BUY	$8.57 - $15.79 $371,912 - $685,238	43,397 Added 84.1%	94,996 $984,000
Q4 2020 Feb 10, 2021	BUY	$5.98 - $12.47 $112,053 - $233,662	18,738 Added 57.02%	51,599 $431,000
Q3 2020 Nov 12, 2020	BUY	$4.65 - $8.73 $48,011 - $90,137	10,325 Added 45.82%	32,861 $203,000
Q2 2020 Aug 11, 2020	BUY	$4.66 - $8.7 $105,017 - $196,063	22,536 New	22,536 $187,000

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $539M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.